However, it was recently reported that IL-27 can inhibit streptozotocin-induced hyperglycemia and pancreatic islet inflammation in an animal model and therefore could represents a potential novel therapeutic approach for T1D [45]. This evidence concerns the gene IL27 and Hyperglycemia.